Altered expression of epidermal growth factor receptor ligands in tumor promoter-treated mouse epidermis and in primary mouse skin tumors induced by an initiation-promotion protocol

Molecular Carcinogenesis

Volumn 22, Issue 2, 1998, Pages 73-83

  Kiguchi, Kaoru ^a   Beltrán, Linda ^a   Rupp, Tim ^a   DiGiovanni, John ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHIREGULIN; BETACELLULIN; CHRYSAROBIN; DIMETHYLBENZ[A]ANTHRACENE; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; KERATINOCYTE GROWTH FACTOR; LIGAND; MESSENGER RNA; PHORBOL 13 ACETATE 12 MYRISTATE; TRANSFORMING GROWTH FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN CARCINOGENESIS; SKIN CARCINOMA; SKIN INJURY; SKIN PAPILLOMA; SKIN TUMOR; SQUAMOUS CELL CARCINOMA; TUMOR PROMOTION;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; CARCINOGENS; CARCINOMA, SQUAMOUS CELL; EPIDERMAL GROWTH FACTOR; FEMALE; FIBROBLAST GROWTH FACTOR 10; FIBROBLAST GROWTH FACTOR 7; FIBROBLAST GROWTH FACTORS; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYCOPROTEINS; GROWTH SUBSTANCES; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LIGANDS; MICE; MICE, INBRED SENCAR; PAPILLOMA; RECEPTOR, EPIDERMAL GROWTH FACTOR; RNA, MESSENGER; SKIN; SKIN NEOPLASMS; TRANSFORMING GROWTH FACTOR ALPHA; UP-REGULATION;

EID: 0031862149     PISSN: 08991987     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2744(199806)22:2<73::AID-MC2>3.0.CO;2-L     Document Type: Article

References (55)

1. Prigent SA, Lemoine MR. The type 1 (EGF-related) family of growth factor receptors and their ligands. Prog Growth Factor Res 4:1-24, 1992.
2. Sasada R, Ono Y, Taniyama Y, Shing Y, Folkman J, Igarashi K. Cloning and expression of cDNA encoding human betacellulin, a new member of the EGF family. Biochem Biophys Res Commun 190:1173-1179, 1993.
3. Salomon DS, Kim N, Saeki T, Ciardiello F. Transforming growth factor α: An oncodevelopmental growth factor. Cancer Cells 2:389-397, 1990.
4. Derynck R. Transforming growth factor α. Cell 54:593-595, 1988.
5. Massague J. Transforming growth factor α: A model for membrane-anchored growth factors. J Biol Chem 265:21393-21396, 1990.
6. DeLarco JE, Todaro GJ. Growth factors from murine sarcoma virus-transformed cells. Proc Natl Acad Sci USA 75:4001-4005, 1978.
7. Anzano MA, Roberts AB, Smith JM, Sporn MB, DeLarco JE. Sarcoma growth factor from conditioned medium of virally transformed cells is composed of both type a and type β transforming growth factors. Proc Natl Acad Sci USA 80:6264-6268, 1983.
8. Coffey Jr RJ, Derynck R, Wilcom JN, et al. Production and autoinduction of transforming growth factor in human keratinocytes. Nature 328:817-820, 1987.
9. Wilcox JN, Derynck R. Localization of cells synthesizing transforming growth factor a mRNA in the mouse brain. J Neurosci 8:1901-1904, 1988.
10. Lazar LM, Blum M. Regional distribution and developmental expression of epidermal growth factor and transforming growth factor a mRNA in mouse brain by quantitative nuclease protection assay. J Neurosci 12:1688-1697, 1992.
11. Snedecker SM, Brown CF, DiAugustine RP. Expression and functional properties of transforming growth factor and epidermal growth factor during mouse mammary gland ductal morphogenesis. Proc Natl Acad Sci USA 88:276-280, 1991.
12. Madtes DK, Raines EW, Sakariassen KS, et al. Induction of transforming growth factor α in activated human alveolar macrophages Cell 53:285-293, 1988.
13. Rappolee DA, Mark D, Banda MJ, Werb Z. Wound macrophages express TGFα and another growth factor in vivo: Analysis by mRNA phenotyping. Science 241:708-712, 1988.
14. Derynck R, Goeddel DV, Ullrich A, et al. Synthesis of mRNAs for transforming growth factor α and β and the epidermal growth factor receptor by human tumors. Cancer Res 47:707-712, 1987.
15. Liu SC, Sanfilippo B, Perroteau I, Derynck R, Salomon DS, Kidwell WR Expression of transforming growth factor α (TGFα) in differentiated rat mammary tumors: Estrogen induction of TGFα production. Mol Endocrinol 1:683-692, 1987.
16. Smith JJ, Derynck R, Korc M. Production of transforming growth factor a in human pancreatic cancer cells. Evidence for a superagonist autocrine cycle. Proc Natl Acad Sci USA 84:7567-7570, 1987.
17. Yeh YC, Tsai JF, Chuang LY, et al. Elevation of transforming growth factor alpha and alpha-fetoprotein levels in patients with hepatocellular carcinoma. Cancer Res 47:896-901, 1987.
18. Bates SE, Davidson NE, Valverius EM, et al. Expression of transforming growth factor α and its messenger ribonucleic acid in human breast cancer: Its regulation by estrogen and its possible functional significance. Mol Endocrinol 2:543-555, 1988.
19. Liu C, Tsao MS, Grisham JW. Transforming growth factors produced by normal and neoplastically transformed rat liver epithelial cells in culture. Cancer Res 48:850-855, 1988.
20. Luetteke NC, Michalopoulos GK, Teixidó J, Gilmore R, Massagué J, Lee DC. Characterization of high molecular weight transforming growth factor a produced by rat hepatocellular carcinoma cells Biochemistry 27:6487-6494, 1988.
21. Mydlo JH, Michaeli J, Cordon-Cardo C, Goldenberg AS, Heston WDW, Fair WR. Expression of transforming growth factor α and epidermal growth factor receptor messenger RNA in neoplastic and nonneoplastic human kidney tissue. Cancer Res 49:3407-3411, 1989.
22. Barton CM, Hall PA, Hughes CM, Gullick WJ, Lemoine NR. Transforming growth factor alpha and epidermal growth factor in human pancreatic cancer. J Pathol 163:111-116, 1991.
23. DiGiovanni J. Multistage carcinogenesis in mouse skin. Pharmacol Ther 54:63-128, 1992.
24. DiGiovanni J. Role of transforming growth factor-α and the epidermal growth factor receptor in multistage mouse skin carcinogenesis. In: Mukhtar H (ed), Skin Cancer: Mechanisms and Human Relevance. CRC Press, Inc., Boca Raton, FL, 1995, pp. 181-197.
25. Wille Jr JJ, Pittelkow MR, Shipley GD, Scotts RE. Integrated control of growth and differentiation of normal human prokeratinocytes cultured in serum-free medium: Clonal analysis, growth kinetics, and cell cycle studies. J Cell Physiol 121:31-44, 1984.
26. Coffey RJ, Spies NJ, Bascom CC, et al. Growth modulation of mouse keratinocytes by transforming growth factors. Cancer Res 48:1596-1602, 1988.
27. Imamoto A, Beltrán LM, DiGiovanni J. Evidence for autocrine/paracrine growth stimulation by transforming growth factor α during the process of skin tumor promotion. Mol Carcinog 4:52-60, 1991.
28. Xian W, Kiguchi K, Imamoto A, Rupp T, Zilberstein A, DiGiovanni J. Activation of the epidermal growth factor receptor by skin tumor promoters and in skin tumors from SENCAR mice. Cell Growth Differ 6:1447-1455, 1995.
29. Vassar R, Fuchs E. Transgenic mice provide new insights into the role of TGFα during epidermal development and differentiation. Genes Dev 5:714-727, 1991.
30. Dominey AM, Wang XJ, King LE, et al. Targeted overexpression of transforming growth factor α in the epidermis of transgenic mice elicits hyperplasia, hyperkeratosis, and spontaneous squamous papillomas. Cell Growth Differ 4:1071-1082, 1993.
31. Glick AB, Sporn MB, Yuspa SH. Altered regulation of TGFβ1 and TGFα in primary keratinocytes and papillomas expressing v-Haras. Mol Carcinog 4:210-219, 1991.
32. Rho O, Beltrán LM, Gimenez-Conti IB, DiGiovanni J. Altered expression of the epidermal growth factor receptor and transforming growth factor during multistage skin carcinogenesis in SENCAR mice. Mol Carcinog 11:19-28, 1994.
33. Ha-induced epidermal neoplasia: Potential involvement of alternate epidermal growth factor receptor ligands. Cancer Res 55:1883-1893, 1995.
34. Cook PW, Mattox PA, Keeble WW, et al. A heparin sulfate-regulated human keratinocyte autocrine factor is similar or identical to amphiregulin. Mol Cell Biol 11:2547-2557, 1991.
35. Hashimoto K, Higashiyama S, Asada H, et al. Heparin-binding epidermal growth factor-like growth factor is an autocrine growth factor for human keratinocytes. J Biol Chem 269:20060-20066, 1994.
36. Vaughan TJ, Pascall JC, Brown KD. Tissue distribution of mRNA for heparin-binding epidermal growth factor. Biochem J 287:681-684, 1992.
37. Gottlieb AB, Chang CK, Posnett DN, Fanelli B, Tam JP. Detection of transforming growth factor in normal, malignant and hyperproliferative human keratinocytes. J Exp Med 167:670-675, 1988.
38. Elder JT, Fisher GJ, Lindquist PB, et al. Overexpression of transforming growth factor a in psoriatic epidermis. Science 243:811-814, 1989.
39. Cook PW, Pittelkow MR, Keeble WW, Graves-Deal R, Coffey Jr RJ, Shipley GD. Amphiregulin messenger RNA is elevated in psoriatic epidermis and gastrointestinal carcinomas. Cancer Res 52:3224-3227, 1992.
40. Johnston GR, Saeki T, Gordon AW, Shoyab M, Salomon DS, Stromberg K. Autocrine action of amphiregulin in a colon carcinoma cell line and immunocytochemical localization of amphiregulin in human colon. J Cell Biol 118:741-751, 1992.
41. Marikovsky M, Breuing K, Liu PY, et al. Appearance of heparin-binding EGF-like growth factor in wound fluid as a response to injury. Proc Natl Acad Sci USA 90:3889-3893, 1993.
42. Dlugosz AA, Cheng C, Denning MF, Dempsey PJ, Coffey RJ, Yuspa SH. Keratinocyte growth factor receptor ligands induce transforming growth factor α expression and activated the epidermal growth factor receptor signaling pathway in cultured epidermal keratinocytes. Cell Growth Differ 5:1283-1292, 1994.
43. DiGiovanni J, Boutwell RK. Tumor promoting activity of 1,8-dihydroxy-3-methyl-9-anthrone (chrysarobin) in female SENCAR mice. Carcinogenesis 4:281-284, 1983.
44. Chomczynski D, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159, 1987.
45. Mason U, Fuller-Pace F, Smith R, Dickson C. FGF-7 (keratinocyte growth factor) expression during mouse development suggests roles in myogenesis, forebrain regionalisation and epithelial-mesenchymal interactions. Mech Dev 45(1):15-30, 1994.
46. Brown K, Bailleul B, Ramsden M, et al. Isolation and characterrization of the 5′ flanking region of the mouse c-Harvey-ras gene. Mol Carcinog 1:161-170, 1988.
47. Singer-Sam J, Robinson MO, Bellvé AR, Simon MI, Riggs AD. Measurement by quantitative PCR of changes in HPRT, PkG-1, PkG-2, APRT, MTase, and Zfy gene transcripts during mouse spermatogenesis. Nucleic Acids Res 18:1255-1259, 1990.
48. Werner S, Peters KG, Longaker MT, Fuller-Pace F, Banda MJ, Williams LT. Large induction of keratinocyte growth factor expression in the dermis during wound healing. Proc Natl Acad Sci USA 89:6896-6900, 1991.
49. Kiguchi K, Beltrán L, You J, Rho O, DiGiovanni J. Elevation of transforming growth factor-α mRNA and protein expression by diverse tumor promoters in SENCAR mouse epidermis. Mol Carcinog 12:225-235, 1995.
50. Chen X, Raab G, Deutsch U, Zhang J, Ezzell RM, Klagsbrun M. Induction of heparin-binding EGF-like growth factor expression during myogenesis. Activation of the gene by MyoD and localization of the transmembrane form of the protein on the myotube surface. J Biol Chem 270:18285-18294, 1995.
51. Kemeny L, Ruzicka T, Braun-Falco I. Dithranol: A review of the mechanism of action in the treatment of psoriasis vulgaris. Skin Pharmacol 3:1-20, 1990.
52. Frenkel K. Carcinogen-mediated oxidant formation and oxidative DNA damage. Pharmacol Ther 53:127-166, 1992.
53. Riese III DJ, Bermingham Y, van Raaij TM, Buckley S, Plowman GD, Stern DF. Betacellulin activates the epidermal growth factor receptor and erbB-4, and induces cellular response patterns distinct from those stimulated by epidermal growth factor or neuregulin-b. Oncogene 12:345-353, 1996.
54. Kiguchi K, Beltrán L, Dubowski A, DiGiovanni J. Analysis of the ability of 12-O-tetradecanoylphorbol-13-acetate to induce epidermal hyperplasia, transforming growth factor-alpha, and skin tumor promotion in wa-1 mice. J Invest Dermatol 108:784-791, 1997.
55. Threadgill DW, Dlugosz AA, Hansen LA, et al. Targeted disruption of mouse EGF receptor: Effect of genetic background on mutant phenotype. Science 269:230-234, 1995.